There have been a lot of advancements on this front too. One promising technique is duodenum resurfacing (DMR). This helps reset some of the insulin sensitivity issues. The one problem we have is that this is a one time low risk procedure compared to selling insulin or GLP-1. Like all of our problems in healthcare, we have a major misalignment in incentives.

[dead]